North Central London
Joint Formulary
 
back
8 Malignant disease and immunosuppression

The formulary for systemic anti-cancer treatments should be viewed alongside the 'National Cancer Drugs Fund list'

https://www.england.nhs.uk/publication/national-cancer-drugs-fund-list/

08-02-04 Interferon Alfa

Interferon Alfa IntronA®
Restricted

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Restricted to Consultant Haematologists and Gastroenterologists only
Link  NICE TA75: Interferon Alfa - Chronic Hepatitis C
 

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF  HCD
Interferon Alfa Roferon-A®
Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Preferred brand for haematology
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF  HCD
Peginterferon Alfa Pegasys®
Restricted

NOTE: There is more than one monograph for PegInterferon Alfa, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Pegasys or ViraferonPeg
  • RFL:
    • Pegasys restricted to hepatology only for the treatment of Hepatitis B.
    • Pegasys (treatment duration over 48 weeks) approved for Hepatitis B and D co-infection (February 2017)
    • Formulary for myelofibrosis, essential thrombocythaemia and polycythaemia 
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Pegasys "Inj Pen 180 micrograms" or ViraferonPeg
Link  NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
Link  NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
Link  NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
Link  NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
Link  NICE TA96: Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B
 

Restricted Drug GP - Red View adult BNF  View SPC online  View childrens BNF  HCD
Peginterferon Alfa ViraferonPeg®
Formulary

NOTE: There is more than one monograph for PegInterferon Alfa, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Pegasys or ViraferonPeg
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Pegasys "Inj Pen 180 micrograms" or ViraferonPeg
Link  NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
Link  NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
 

GP - Red View adult BNF  View SPC online  View childrens BNF  HCD
Interferon Alfa Viraferon®
Non Formulary

GP - Red View adult BNF  View SPC online  View childrens BNF  HCD